⌘K

Login Start Free

Home/Filings/4/0001305387-05-000001

4//SEC Filing

Bedard John F 4

Accession 0001305387-05-000001

CIK 0001013351other

View on SEC.gov Company Profile

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 2:47 PM ET

Size

7.8 KB

Accession

0001305387-05-000001

Insider Transaction Report

Form 4

Period: 2005-02-18

MAXIM PHARMACEUTICALS INCmaxm

Director

Transactions

Award
Option to purchase
2005-02-18$1.64/sh+24,375$39,975→ 24,375 total
Exercise: $1.64From: 2005-02-18Exp: 2015-02-18→ common stock (24,375 underlying)
Award
Option to Purchase
2005-02-18$1.64/sh+25,000$41,000→ 25,000 total
Exercise: $1.64From: 2005-09-30Exp: 2015-02-18→ Common stock (25,000 underlying)

Footnotes (2)

[F1]100% vested
[F2]Contigent upon particiapting in at least 75% of Board Meetings during year ended Sept., 30, 2005

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

MAXIM PHARMACEUTICALS INC

CIK 0001013351

Entity typeother

Related Parties

1

filerCIK 0001305387

Filing Metadata

Form type: 4
Filed: Feb 21, 7:00 PM ET
Accepted: Feb 22, 2:47 PM ET
Size: 7.8 KB

View on SEC.gov